期刊文献+

两性霉素B脂质体冻干粉的制备与性质

Preparation and Properties of Amphotericin B Liposome Freeze-Dried Powder
下载PDF
导出
摘要 目的:以薄膜分散法制备两性霉素B脂质体冻干粉(AMB-Lip-FDP),并进行其质量评价。方法:采用薄膜分散法制备AMB-Lip-FDP,考察冻干工艺对AMB-Lip-FDP外观、溶解性、粒径和包封率的影响,并对制备的冻干粉性质进行表征。结果:采用薄膜分散法制备的AMB-Lip-FDP为黄色蓬松粉末,溶解性好,略有引湿性,复溶后的平均粒径为(110.2±3.6)nm,PDI为0.187±0.026,Zeta电位为(-42.6±1.4)mV,包封率为93.6%±2.7%,稳定性较好。体外释放结果表明,PBS中48 h释放约65%,具有明显的缓释性。5%葡萄糖注射液稀释,室温48 h稳定。结论:采用优化后工艺制备AMB-Lip-FDP稳定可行,具有明显缓释特征,为该产品的生物等效性评价提供研究基础。 Objective:The Amphotericin B liposome freeze-dried powder(AMB-Lip-FDP)were prepared by film dispersion method,and investigate its quality.Methods:AMB-Lip-FDP was prepared by film dispersion method.Taking appearance,solubility,particle size,encapsulation efficiency as evaluation indicators,the lyophilization process was investigated,and then the properties of the prepared lyophilized powder were characterized.Results:AMB-Lip-FDP which prepared by film dispersion method was a fluffy yellow powder with good solubility,slight moisture attraction.The average particle size after reconstraction was(110.2±3.6)nm,PDI was 0.187±0.026,Zeta potential was(-42.6±1.4)mV,the encapsulation efficiency was 93.6%±2.7%,and the stability is good.In vitro release experiments showed that the preparation was released slowly in PBS and its release rate was about 65% at 48 h.Diluted with 5% glucose injection,it was stable within 48 hours at room temperature.Conclusion:AMB-Lip-FDP prepared by the optimal process is stable and feasible,with obvious sustained-release characteristics,providing a research basis for the bioequivalence evaluation of amphotericin B liposome.
作者 王秋云 潘颖彬 黎芷晖 Wang Qiuyun;Pan Yingbin;Li Zhihui(Bostal Drug Delivery Co.,Ltd.,Guangzhou 510530,China)
出处 《山东化工》 CAS 2023年第19期20-23,共4页 Shandong Chemical Industry
关键词 两性霉素B 脂质体 冻干粉 薄膜分散法 amphotericin B liposomes freeze-dried powder film dispersion method
  • 相关文献

参考文献2

二级参考文献77

  • 1Mochon A B, Ye J, Kayalam A, et al. Serological profiling of Candida albicans protein microarray reveals permanent hostpathogen interplay and stage-specific responses during Candidemia[J]. PLoS Pathog, 2010, 6(3): el 000827.
  • 2Zaoutis T E, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis[J]. Clin Infect Dis, 2005, 41 (9): 1232-1239.
  • 3De Luca C, Guglilminetti M, Ferrario A, et al. Candidemia: species involved, virulence factors and antimycotic susceptibility[J]. New Microbiol, 2012, 35(4): 459-468.
  • 4Leroy O, Gangneux J P, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candidainfections in critical care: a multicenter, prospective, observational study in France (2005-2006)[J]. Crit Care Med, 2009, 37(5): 1612-1618.
  • 5Brennan B, Leyden J J. Overview of topical therapy for common superficial fungal infections and the role of new topical agents[J]. JAm Acad Dermatol, 1997, 36(2 Pt 1): S3-S8.
  • 6Pfaller M A, Espinel-lngroff A, Canton E, et al. Wild-Type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution[J]. J Clin Microbiol, 2012, 50(6): 2040-2046.
  • 7Mikulska M, Del Bono V, Ratto S, et al. Occurrence, presentation and treatment of candidemia[J]. Expert Rev Clin Immunol, 2012, 8(8): 755-765.
  • 8Zhang X B, Yu S J, Yu J X, et al. Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009[J]. Jpn J Infect Dis, 2012, 65(6): 510-515.
  • 9Jung S I, Shin J H, Choi H J, et al. Antifungal susceptibility to amphotericin 13, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea[J]. Ann Lab Med, 2012, 32(6): 426-428.
  • 10Jung S I, Shin J H, Choi H J, et al. Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea[J]. Med Mycol, 2010, 48(4): 669-674.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部